Difficulty: Medium
Average Score: 88%
Practice
A 53-year-old man with chronic neuropathic back pain and depression is managed with amitriptyline. He has recently complained of urinary frequency and was given a prescription for Ditropan. He now complains of acute abdominal pain and is unable to pass flatus or bowel movement. What is the most likely explanation of this finding?
Correct answer
C
Rationale
In this scenario, the most likely explanation for the patient's symptoms of acute abdominal pain, inability to pass flatus or bowel movement after being prescribed Ditropan for urinary frequency while on amitriptyline is paralytic ileus (Option C). Paralytic ileus is a condition characterized by the temporary cessation of bowel motility, which can be caused by certain medications like anticholinergics such as Ditropan.
Option A, alcoholic hepatitis, is less likely in this case as the patient's symptoms are more indicative of a gastrointestinal issue rather than liver inflammation. Option B, pancreatitis, is also less likely as the symptoms presented are more consistent with a bowel motility issue rather than pancreatic inflammation. Option D, a supratherapeutic dose of medication, is not the most likely explanation as the symptoms are more in line with a side effect of the medication rather than an overdose.
Educationally, this case highlights the importance of recognizing potential adverse effects and drug interactions when managing patients on multiple medications. Understanding the mechanisms of action and side effect profiles of medications is crucial in providing safe and effective patient care. It also underscores the need for thorough patient assessment and monitoring to promptly identify and address any complications that may arise during pharmacological management.
Option A, alcoholic hepatitis, is less likely in this case as the patient's symptoms are more indicative of a gastrointestinal issue rather than liver inflammation. Option B, pancreatitis, is also less likely as the symptoms presented are more consistent with a bowel motility issue rather than pancreatic inflammation. Option D, a supratherapeutic dose of medication, is not the most likely explanation as the symptoms are more in line with a side effect of the medication rather than an overdose.
Educationally, this case highlights the importance of recognizing potential adverse effects and drug interactions when managing patients on multiple medications. Understanding the mechanisms of action and side effect profiles of medications is crucial in providing safe and effective patient care. It also underscores the need for thorough patient assessment and monitoring to promptly identify and address any complications that may arise during pharmacological management.